Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
| 158.54 Delayed Data As of Jul 01 |  +2.53 / +1.62%Today’s Change | 117.64 Today|||52-Week Range 186.22 | +24.44% Year-to-Date |
Latest JAZZ News | Press Releases
| What Bear Market? These 2 Stocks Are Killing It. Jul 01 / MotleyFool.com - Paid Partner Content | Stock Market Plunge: 5 Unstoppable Stocks Begging to Be Bought Jun 28 / MotleyFool.com - Paid Partner Content |
| Axsome (AXSM) Hurt by Regulatory Setbacks: Will It Recover? Jun 30 / Zacks.com - Paid Partner Content | Are Options Traders Betting on a Big Move in Jazz Pharmaceuticals (JAZZ) Stock? Jun 23 / Zacks.com - Paid Partner Content |
| JAZZ's Late-Stage Multiple Sclerosis Study on Nabiximols Fails Jun 29 / Zacks.com - Paid Partner Content | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Jun 22 / Zacks.com - Paid Partner Content |
| Axsome (AXSM) Surges Following FDA Label Proposal for AXS-05 Jun 28 / Zacks.com - Paid Partner Content | 3 Stocks That Could Double by 2025 Jun 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 156.01 |
| Today’s open | 155.32 |
| Day’s range | 154.12 - 159.28 |
| Volume | 13,784 |
| Average volume (3 months) | 571,768 |
| Market cap | $9.6B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -228.94% |
| Earnings growth (this year) | +5.01% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +30.91% |
| P/E ratio | NM |
| Price/Sales | 2.46 |
| Price/Book | 2.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHVNBiohaven Pharmaceuti... | -0.33 | -0.23% |
| RDYDr Reddy's Laborator... | +0.42 | +0.76% |
| RGENRepligen Corp | +4.29 | +2.64% |
| UTHRUnited Therapeutics ... | +2.40 | +1.02% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | $4.19 |
| Annual revenue (last year) | $3.1B |
| Annual profit (last year) | -$329.7M |
| Net profit margin | -10.65% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
